Statement
to the Blood Products Advisory Committee
Open Public Hearing on OTC, Home-use, Rapid HIV Tests
ASHA
has been informing the public about, and advocating for, the prevention of
sexually transmitted diseases since 1914.
Since our inception we have encouraged early diagnosis and treatment as
a way to reduce further transmission in the community.
The
Centers for Disease Control and Prevention (CDC) currently estimates that about
250,000 people in the United States are infected
yet unaware of their human immunodeficiency virus (HIV) status. Since HIV
infection often takes a decade to develop into acquired immunodeficiency syndrome
(AIDS), people living with HIV who remain undiagnosed risk spreading HIV
without their knowledge for many years.
For
decades, ASHA has been an advocate of broader availability and use of HIV tests
to facilitate more rapid diagnosis and treatment for those infected and to
prevent further transmission. Unfortunately, many people avoid or are unable to
get tested in clinics or a physician’s office for a variety of reasons,
including lack of access to health care services, distrust of the healthcare
system, and the stigma of discovery.
We
support CDC’s goals to implement new models for diagnosing HIV infection
outside medical settings and to prevent new infections by working with persons
diagnosed with HIV and their partners. A greater set of options, including
over-the-counter, home-use, rapid HIV tests, may increase the number of people
willing to be tested.
Clearly,
it would be preferable for all individuals seeking HIV testing to receive pre-
and post-test counseling in a supportive environment. However, the availability
of these home-use tests could be a very powerful strategy to reduce barriers to
testing and increase early detection of HIV infection.
It
is imperative that those who test negative fully understand the implications of
their test results, and those who test positive to have immediate access to
counseling services and referral to quality medical care.
In
closing, we ask that the Blood Products Advisory Committee recommend the
approval of the over-the-counter, home-use, rapid HIV test.